David Steffin
Impact in
-
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 7
- CAR-T cell therapy research 7
-
- Immune Cell Function and Interaction 4
- Immunodeficiency and Autoimmune Disorders 1
- Co-authors
- Emily M. Hsieh (1 shared paper)Helen Elisabeth Heslop (3 shared papers)Rayne Helen Rouce (2 shared papers)Tao Wang (2 shared papers)Mae Louise Woods (1 shared paper)Meng-Fen Wu (2 shared papers)Cliona M. Rooney (1 shared paper)Sachin G. Thakkar (1 shared paper)
- Journals
- Pediatric Blood & Cancer (1 paper)JCO Oncology Practice (1 paper)Cytotherapy (1 paper)Molecular Therapy (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
David Steffin
11 papers receiving 284 citations
David Steffin's Hit Papers
Peers
Comparison fields: 5 of 37
- Oncology 198
- Immunology 57
- Genetics 41
- Molecular Biology 53
- Hematology 7
Countries citing papers authored by David Steffin
This map shows the geographic impact of David Steffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Steffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Steffin more than expected).
Fields of papers citing papers by David Steffin
This network shows the impact of papers produced by David Steffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Steffin. The network helps show where David Steffin may publish in the future.
Co-authors
The 25 scholars most cited alongside David Steffin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers Hit paper breakdown → | 2024 | 160 |
| 2 | 2022 | 39 | |
| 3 | Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma Hit paper breakdown → | 2025 | 37 |
| 4 | 2019 | 17 | |
| 5 | 2022 | 7 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 6 | |
| 8 | 2019 | 5 | |
| 9 | 2024 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2026 | 0 | |
| 13 | 2022 | 0 | |
| 14 | 2025 | 0 |
About David Steffin
David Steffin is a scholar working on Oncology, Immunology, Genetics, Hematology and Neurology, having authored 14 papers that have together received 289 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (4 papers), Virus-based gene therapy research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Neuroblastoma Research and Treatments (2 papers), CRISPR and Genetic Engineering (1 paper), Silicon Carbide Semiconductor Technologies (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Oncology (198 citations), Immunology (57 citations), Genetics (41 citations), Molecular Biology (53 citations) and Hematology (7 citations). David Steffin has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Emily M. Hsieh, Helen Elisabeth Heslop, Rayne Helen Rouce, Tao Wang, Mae Louise Woods, Meng-Fen Wu, Cliona M. Rooney, Sachin G. Thakkar, Bambi Grilley and Chrystal Ursula Louis. Their work appears in journals such as Pediatric Blood & Cancer, JCO Oncology Practice, Cytotherapy, Molecular Therapy and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.